News & Events

Philogen to attend European Society for Medical Oncology, Paris (9-13 September 2022)

Philogen attends ESMO in September 2022.

Tobias Weiss, MD/PhD, Neuro-Oncologist at the Universitätsspital Zürich, to give a presentation entitled “The combination of lomustine and antibody-based targeted TNF (L19TNF) as a promising treatment for recurrent glioblastoma” on the 10th of September.

Please visit ESMO 2022 Website for more details.